|
More articles from Pharma Marketletter
Accentia agrees with FDA on Revimmune trial.(Brief article), October 15, 2007
UCB's Neupro effective for motor impairment in PD.(Brief article), October 15, 2007
Mayo Clinic team uses Ab to trigger remyelination.(Antibodies)(Brief a..., October 15, 2007
New tool for R&D from Symyx Tech.(Symyx Technologies)(research and dev..., October 15, 2007
Mimotopes in deal with BHRI.(Baker Heart Research Institute)(Brief art..., October 15, 2007
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
